KRAS and non-small cell lung carcinoma: Interestingly, PDK-1 has been also described to promote tumor cell proliferation and migration in non-small cell lung cancer (NSCLC) by enhancing the Warburg effect 7 and previous works demonstrate tight correlation between abnormal cancer cell metabolism and KRAS mutation in several neoplasias.